Relationship between matrix metalloproteinase-2 activity and cystatin C levels in patients with hepatic disease

Tzy Yen Chen, Yih Shou Hsieh, Chi Chieh Yang, Chi Ping Wang, Shun Fa Yang, Yan Wen Cheng, Hui Ling Chiou

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objectives: A direct relationship between cystatin C levels and the severity of hepatic disease has been revealed in our previous study. This study was aimed to consider whether a correlation exists between matrix metalloproteinases (MMPs), which have been proven to be involved in liver cirrhosis, and cystatin C to reflect the severity of hepatic disease. Design and Methods: A total of 154 consecutive patients with various liver diseases were recruited to determine their serum levels of cystatin C, MMP-2 and-9, together with other hepatic parameters. These were compared with 40 normal controls. Results: Average levels of MMP-2 and cystatin C were significantly higher in patients while MMP-9 was significantly lower, as compared to controls. A linear regression analysis has revealed a direct relationship between cystatin C and MMP-2 (Y = 83.39 + 270.56X, R = 0.38, P <0.001), as well as between MMP-2 and the severity of liver diseases. Conclusion: This is the first study to demonstrate a correlation between cystatin C and MMP-2, suggesting that there may be certain interactions between cystatin C and MMP-2 in patients with hepatic diseases.

Original languageEnglish
Pages (from-to)632-638
Number of pages7
JournalClinical Biochemistry
Volume38
Issue number7
DOIs
Publication statusPublished - Jul 2005
Externally publishedYes

Fingerprint

Cystatin C
Matrix Metalloproteinase 2
Liver
Matrix Metalloproteinase 9
Liver Diseases
Matrix Metalloproteinases
Linear regression
Regression analysis
Liver Cirrhosis
Linear Models
Regression Analysis
Serum

Keywords

  • Cystatin C
  • Hepatic disease
  • MMP-2

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Chen, T. Y., Hsieh, Y. S., Yang, C. C., Wang, C. P., Yang, S. F., Cheng, Y. W., & Chiou, H. L. (2005). Relationship between matrix metalloproteinase-2 activity and cystatin C levels in patients with hepatic disease. Clinical Biochemistry, 38(7), 632-638. https://doi.org/10.1016/j.clinbiochem.2005.03.005

Relationship between matrix metalloproteinase-2 activity and cystatin C levels in patients with hepatic disease. / Chen, Tzy Yen; Hsieh, Yih Shou; Yang, Chi Chieh; Wang, Chi Ping; Yang, Shun Fa; Cheng, Yan Wen; Chiou, Hui Ling.

In: Clinical Biochemistry, Vol. 38, No. 7, 07.2005, p. 632-638.

Research output: Contribution to journalArticle

Chen, Tzy Yen ; Hsieh, Yih Shou ; Yang, Chi Chieh ; Wang, Chi Ping ; Yang, Shun Fa ; Cheng, Yan Wen ; Chiou, Hui Ling. / Relationship between matrix metalloproteinase-2 activity and cystatin C levels in patients with hepatic disease. In: Clinical Biochemistry. 2005 ; Vol. 38, No. 7. pp. 632-638.
@article{d78ada2b97564766832f309e7a43b11b,
title = "Relationship between matrix metalloproteinase-2 activity and cystatin C levels in patients with hepatic disease",
abstract = "Objectives: A direct relationship between cystatin C levels and the severity of hepatic disease has been revealed in our previous study. This study was aimed to consider whether a correlation exists between matrix metalloproteinases (MMPs), which have been proven to be involved in liver cirrhosis, and cystatin C to reflect the severity of hepatic disease. Design and Methods: A total of 154 consecutive patients with various liver diseases were recruited to determine their serum levels of cystatin C, MMP-2 and-9, together with other hepatic parameters. These were compared with 40 normal controls. Results: Average levels of MMP-2 and cystatin C were significantly higher in patients while MMP-9 was significantly lower, as compared to controls. A linear regression analysis has revealed a direct relationship between cystatin C and MMP-2 (Y = 83.39 + 270.56X, R = 0.38, P <0.001), as well as between MMP-2 and the severity of liver diseases. Conclusion: This is the first study to demonstrate a correlation between cystatin C and MMP-2, suggesting that there may be certain interactions between cystatin C and MMP-2 in patients with hepatic diseases.",
keywords = "Cystatin C, Hepatic disease, MMP-2",
author = "Chen, {Tzy Yen} and Hsieh, {Yih Shou} and Yang, {Chi Chieh} and Wang, {Chi Ping} and Yang, {Shun Fa} and Cheng, {Yan Wen} and Chiou, {Hui Ling}",
year = "2005",
month = "7",
doi = "10.1016/j.clinbiochem.2005.03.005",
language = "English",
volume = "38",
pages = "632--638",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Relationship between matrix metalloproteinase-2 activity and cystatin C levels in patients with hepatic disease

AU - Chen, Tzy Yen

AU - Hsieh, Yih Shou

AU - Yang, Chi Chieh

AU - Wang, Chi Ping

AU - Yang, Shun Fa

AU - Cheng, Yan Wen

AU - Chiou, Hui Ling

PY - 2005/7

Y1 - 2005/7

N2 - Objectives: A direct relationship between cystatin C levels and the severity of hepatic disease has been revealed in our previous study. This study was aimed to consider whether a correlation exists between matrix metalloproteinases (MMPs), which have been proven to be involved in liver cirrhosis, and cystatin C to reflect the severity of hepatic disease. Design and Methods: A total of 154 consecutive patients with various liver diseases were recruited to determine their serum levels of cystatin C, MMP-2 and-9, together with other hepatic parameters. These were compared with 40 normal controls. Results: Average levels of MMP-2 and cystatin C were significantly higher in patients while MMP-9 was significantly lower, as compared to controls. A linear regression analysis has revealed a direct relationship between cystatin C and MMP-2 (Y = 83.39 + 270.56X, R = 0.38, P <0.001), as well as between MMP-2 and the severity of liver diseases. Conclusion: This is the first study to demonstrate a correlation between cystatin C and MMP-2, suggesting that there may be certain interactions between cystatin C and MMP-2 in patients with hepatic diseases.

AB - Objectives: A direct relationship between cystatin C levels and the severity of hepatic disease has been revealed in our previous study. This study was aimed to consider whether a correlation exists between matrix metalloproteinases (MMPs), which have been proven to be involved in liver cirrhosis, and cystatin C to reflect the severity of hepatic disease. Design and Methods: A total of 154 consecutive patients with various liver diseases were recruited to determine their serum levels of cystatin C, MMP-2 and-9, together with other hepatic parameters. These were compared with 40 normal controls. Results: Average levels of MMP-2 and cystatin C were significantly higher in patients while MMP-9 was significantly lower, as compared to controls. A linear regression analysis has revealed a direct relationship between cystatin C and MMP-2 (Y = 83.39 + 270.56X, R = 0.38, P <0.001), as well as between MMP-2 and the severity of liver diseases. Conclusion: This is the first study to demonstrate a correlation between cystatin C and MMP-2, suggesting that there may be certain interactions between cystatin C and MMP-2 in patients with hepatic diseases.

KW - Cystatin C

KW - Hepatic disease

KW - MMP-2

UR - http://www.scopus.com/inward/record.url?scp=21844476763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21844476763&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiochem.2005.03.005

DO - 10.1016/j.clinbiochem.2005.03.005

M3 - Article

C2 - 16009142

AN - SCOPUS:21844476763

VL - 38

SP - 632

EP - 638

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 7

ER -